These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11578108)

  • 1. Hexarelin--evaluation of factors influencing oral bioavailability and ways to improve absorption.
    Westberg C; Benkestock K; Fatouros A; Svensson M; Sjöström B
    J Pharm Pharmacol; 2001 Sep; 53(9):1257-64. PubMed ID: 11578108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a drug-delivery system consisting of soybean phosphatidyl choline and medium-chain monoacylglycerol on the intestinal permeability of hexarelin in the rat.
    Fagerholm U; Sjöström B; Sroka-Markovic J; Wijk A; Svensson M; Lennernäs H
    J Pharm Pharmacol; 1998 May; 50(5):467-73. PubMed ID: 9643439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of the peptidic GH secretagogues hexarelin and EP 51389, across rat jejunum.
    Roumi M; Kwong E; Deghenghi R; Locatelli V; Marleau S; Du Souich P; Béliveau R; Ong H
    Peptides; 2001 Jul; 22(7):1129-38. PubMed ID: 11445244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
    Ghigo E; Arvat E; Gianotti L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F
    J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
    Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart.
    Bodart V; Bouchard JF; McNicoll N; Escher E; Carrière P; Ghigo E; Sejlitz T; Sirois MG; Lamontagne D; Ong H
    Circ Res; 1999 Oct; 85(9):796-802. PubMed ID: 10532947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
    Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
    Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement.
    Sjöström M; Lindfors L; Ungell AL
    Pharm Res; 1999 Jan; 16(1):74-9. PubMed ID: 9950282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
    Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
    J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone secretagogue (GHS) analogue, hexarelin stimulates GH from peripheral lymphocytes.
    Poppi L; Dixit VD; Baratta M; Giustina A; Tamanini C; Parvizi N
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):343-7. PubMed ID: 12397533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Eur J Pharmacol; 1997 Sep; 334(2-3):201-7. PubMed ID: 9369349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of growth hormone-releasing activity of hexarelin in man.
    Arvat E; Gianotti L; Di Vito L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1995 Jan; 61(1):51-6. PubMed ID: 7731498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
    Conley LK; Teik JA; Deghenghi R; Imbimbo BP; Giustina A; Locatelli V; Wehrenberg WB
    Neuroendocrinology; 1995 Jan; 61(1):44-50. PubMed ID: 7731497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
    De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
    J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
    Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats.
    Dahlgren D; Olander T; Sjöblom M; Hedeland M; Lennernäs H
    Acta Pharm Sin B; 2021 Jun; 11(6):1667-1675. PubMed ID: 34221875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
    Torsello A; Luoni M; Grilli R; Guidi M; Wehrenberg WB; Deghenghi R; Müller EE; Locatelli V
    Neuroendocrinology; 1997 Feb; 65(2):91-7. PubMed ID: 9067986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling.
    Ong H; McNicoll N; Escher E; Collu R; Deghenghi R; Locatelli V; Ghigo E; Muccioli G; Boghen M; Nilsson M
    Endocrinology; 1998 Jan; 139(1):432-5. PubMed ID: 9421445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
    Broglio F; Guarracino F; Benso A; Gottero C; Prodam F; Granata R; Avogadri E; Muccioli G; Deghenghi R; Ghigo E
    Eur J Pharmacol; 2002 Jul; 448(2-3):193-200. PubMed ID: 12144941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.